Toby M Maher Selected Research

Idiopathic Pulmonary Fibrosis

1/2022	Biomarker signatures for progressive idiopathic pulmonary fibrosis.
1/2022	Autoantibodies are present in the bronchoalveolar lavage but not circulation in patients with fibrotic interstitial lung disease.
1/2022	Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis.
1/2022	Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung Diseases.
1/2022	Candidate Role for Toll-like Receptor 3 L412F Polymorphism and Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
1/2022	CYFRA 21-1 Predicts Progression in Idiopathic Pulmonary Fibrosis: A Prospective Longitudinal Analysis of the PROFILE Cohort.
1/2022	Biomarkers for Interstitial Lung Abnormalities: A Stepping-stone Toward Idiopathic Pulmonary Fibrosis Prevention?
12/2021	Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD).
1/2021	Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis.
1/2021	Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toby M Maher Research Topics

Disease

73	Idiopathic Pulmonary Fibrosis 01/2022 - 04/2009
29	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2022 - 07/2012
27	Disease Progression 01/2022 - 04/2013
25	Fibrosis (Cirrhosis) 05/2022 - 04/2009
15	Pulmonary Fibrosis (Fibrosing Alveolitis) 03/2022 - 09/2009
14	Systemic Scleroderma (Systemic Sclerosis) 05/2022 - 04/2013
13	Lung Diseases (Lung Disease) 01/2022 - 11/2009
6	Infections 01/2022 - 09/2013
4	Dyspnea (Shortness of Breath) 03/2022 - 11/2009
4	Cough 03/2022 - 10/2017
4	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2022 - 08/2013
4	Connective Tissue Diseases (Connective Tissue Disease) 01/2022 - 09/2012
4	Sarcoidosis (Schaumann Disease) 01/2018 - 05/2013
3	Pulmonary Sarcoidosis 11/2020 - 02/2014
3	Neoplasms (Cancer) 01/2016 - 01/2013
3	Pulmonary Hypertension 07/2014 - 12/2008
3	Pneumonia (Pneumonitis) 04/2014 - 06/2007
2	Exanthema (Rash) 12/2020 - 01/2020
2	Diarrhea 12/2020 - 01/2019
2	Frailty 01/2019 - 01/2015
2	Respiratory Tract Infections (Respiratory Tract Infection) 10/2018 - 01/2018
2	Idiopathic Interstitial Pneumonias 07/2014 - 07/2012
2	Lung Injury 09/2009 - 04/2009
1	Chronic Disease (Chronic Diseases) 05/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Pseudomonas Infections 01/2022
1	Lymphocytosis 01/2022
1	COVID-19 07/2021
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 07/2021
1	Vomiting 12/2020
1	Nausea 12/2020

Drug/Important Bio-Agent (IBA)

24	nintedanibIBA 05/2022 - 01/2013
20	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2013
17	pirfenidoneIBA 01/2022 - 04/2014
10	Carbon MonoxideIBA 01/2021 - 05/2013
8	Bleomycin (Blenoxane)FDA LinkGeneric 10/2020 - 04/2009
7	Pharmaceutical PreparationsIBA 01/2021 - 11/2009
6	Oxygen (Dioxygen)IBA 05/2022 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2015
5	CollagenIBA 01/2021 - 06/2015
4	Rituximab (Mabthera)FDA Link 01/2017 - 09/2012
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 11/2009
3	IntegrinsIBA 03/2020 - 01/2020
3	catch-relaxing peptide (Mytilus)IBA 07/2019 - 06/2015
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2022 - 01/2020
2	antigen CYFRA21.1IBA 01/2022 - 01/2022
2	Antiviral Agents (Antivirals)IBA 01/2022 - 09/2013
2	Immunoglobulin G (IgG)IBA 01/2022 - 07/2021
2	Lysophosphatidic Acid ReceptorsIBA 12/2021 - 04/2009
2	Monoclonal AntibodiesIBA 01/2021 - 04/2014
2	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 12/2020 - 02/2018
2	cyclopropapyrroloindoleIBA 01/2020 - 02/2014
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2020 - 04/2009
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 01/2018
2	LigandsIBA 01/2020 - 01/2018
2	prednylidene (Pred)IBA 03/2019 - 11/2016
2	Phosphotransferases (Kinase)IBA 01/2019 - 01/2016
2	Tyrosine Kinase InhibitorsIBA 01/2019 - 09/2017
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019 - 04/2014
2	GLPG1690IBA 01/2019 - 01/2018
2	omipalisibIBA 01/2019 - 01/2016
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2018 - 01/2018
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 04/2013
2	AntacidsIBA 01/2017 - 01/2016
2	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2017 - 04/2014
2	AnticoagulantsIBA 11/2016 - 01/2016
2	TriazolesIBA 03/2014 - 08/2008
2	Antifungal AgentsIBA 03/2014 - 08/2008
1	ametantrone (HAQ)IBA 05/2022
1	Morphine (MS Contin)FDA LinkGeneric 03/2022
1	Opioid Analgesics (Opioids)IBA 03/2022
1	Toll-Like Receptor AgonistsIBA 01/2022
1	Toll-Like Receptor 3IBA 01/2022
1	AutoantigensIBA 01/2022
1	AutoantibodiesIBA 01/2022
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 01/2022
1	BI 1015550IBA 01/2022
1	Keratins (Keratin)IBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	FlagellinIBA 01/2022
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2022
1	Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric 01/2022
1	16S Ribosomal RNAIBA 01/2022
1	Antifibrotic AgentsIBA 12/2021
1	RNA (Ribonucleic Acid)IBA 07/2021
1	Galectins (Galectin)IBA 01/2021
1	Galectin 3 (LGALS3)IBA 01/2021
1	InterleukinsIBA 01/2021
1	AntigensIBA 01/2021
1	InflammasomesIBA 01/2021
1	lebrikizumabIBA 01/2021
1	LectinsIBA 01/2021
1	itaconic acidIBA 10/2020

Therapy/Procedure

30	Therapeutics 05/2022 - 08/2008
3	Drug Therapy (Chemotherapy) 01/2020 - 01/2012
3	Lung Transplantation 01/2015 - 06/2007
2	Precision Medicine 02/2022 - 09/2015
1	Artificial Respiration (Mechanical Ventilation) 07/2021
1	Noninvasive Ventilation 01/2021